Effects of Accelerated rTMS On Motor and Cognitive Function in Parkinson's Disease
NCT07554833
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
Parkinson's disease (PD) is a brain disorder that causes progressive problems with movement, such as slowness, stiffness, tremor, and difficulty walking. Many people with PD also develop problems with thinking and memory. Current medications can help control movement symptoms but often become less effective over time and may cause side effects. There is a need for additional treatment options that can address both movement and thinking difficulties in PD.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- PARKINSON DISEASE (Disorder)
- Parkinson s Disease
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 50 to 90 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- San Francisco Neurology and Sleep Center
- Last updated on ClinicalTrials.gov
- June 16, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- San Francisco Neurology and Sleep Center · San Francisco, CA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.